Christoffer Hedetoft

422 total citations
11 papers, 182 citations indexed

About

Christoffer Hedetoft is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Christoffer Hedetoft has authored 11 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in Christoffer Hedetoft's work include Diabetes and associated disorders (5 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (5 papers). Christoffer Hedetoft is often cited by papers focused on Diabetes and associated disorders (5 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (5 papers). Christoffer Hedetoft collaborates with scholars based in Denmark and Germany. Christoffer Hedetoft's co-authors include Burkhard Göke, Christian Peiser, R. Lang, Hans-Christoph Fehmann, Søren Gräs, Jan Fahrenkrug, Anne Rasmussen, Klaus Kølendorf, H R Christensen and Signe Unmack Larsen and has published in prestigious journals such as Free Radical Biology and Medicine, Biology of Reproduction and Peptides.

In The Last Decade

Christoffer Hedetoft

11 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoffer Hedetoft Denmark 7 72 65 63 41 37 11 182
Orla Woodward United Kingdom 6 52 0.7× 51 0.8× 33 0.5× 17 0.4× 6 0.2× 6 135
Melchor Alpízar Salazar Mexico 7 118 1.6× 17 0.3× 46 0.7× 14 0.3× 25 0.7× 20 287
Mayra Mayumi Kamiji Brazil 9 21 0.3× 156 2.4× 74 1.2× 99 2.4× 40 1.1× 11 298
Jean-Sébastien Wattez United States 12 20 0.3× 28 0.4× 68 1.1× 38 0.9× 73 2.0× 14 356
J Beety United Kingdom 4 188 2.6× 138 2.1× 96 1.5× 56 1.4× 15 0.4× 5 349
Jens Zimmermann Germany 5 65 0.9× 99 1.5× 47 0.7× 41 1.0× 30 0.8× 6 193
Yiin Ling France 9 33 0.5× 68 1.0× 20 0.3× 16 0.4× 36 1.0× 10 226
Xiaotuan Zhao United States 10 25 0.3× 77 1.2× 91 1.4× 84 2.0× 9 0.2× 15 317
Aaron A. May‐Zhang United States 7 21 0.3× 53 0.8× 62 1.0× 32 0.8× 12 0.3× 12 210
Preeshila Behary United Kingdom 10 125 1.7× 81 1.2× 179 2.8× 26 0.6× 8 0.2× 13 333

Countries citing papers authored by Christoffer Hedetoft

Since Specialization
Citations

This map shows the geographic impact of Christoffer Hedetoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoffer Hedetoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoffer Hedetoft more than expected).

Fields of papers citing papers by Christoffer Hedetoft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoffer Hedetoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoffer Hedetoft. The network helps show where Christoffer Hedetoft may publish in the future.

Co-authorship network of co-authors of Christoffer Hedetoft

This figure shows the co-authorship network connecting the top 25 collaborators of Christoffer Hedetoft. A scholar is included among the top collaborators of Christoffer Hedetoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoffer Hedetoft. Christoffer Hedetoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kristensen, Peter Lommer, Amra Ciric Alibegovic, Henrik U. Andersen, et al.. (2023). Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia. Diabetes Obesity and Metabolism. 25(6). 1557–1565. 4 indexed citations
2.
Alibegovic, Amra Ciric, Henrik U. Andersen, Henning Beck‐Nielsen, et al.. (2022). Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia. Diabetes Technology & Therapeutics. 24(9). 643–654. 4 indexed citations
3.
Larsen, Emil List, Louise Lundby‐Christensen, Trine Welløv Boesgaard, et al.. (2021). Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. Free Radical Biology and Medicine. 178. 18–25. 1 indexed citations
4.
Pedersen‐Bjergaard, Ulrik, Amra Ciric Alibegovic, Henrik U. Andersen, et al.. (2021). Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial. Diabetes Obesity and Metabolism. 24(2). 257–267. 7 indexed citations
5.
Alibegovic, Amra Ciric, Henrik U. Andersen, Henning Beck‐Nielsen, et al.. (2019). The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design. BMC Endocrine Disorders. 19(1). 78–78. 7 indexed citations
6.
Hedetoft, Christoffer, et al.. (2008). Four-fold increase in foot ulcers in type 2 diabetic subjects without an increase in major amputations by a multidisciplinary setting. Diabetes Research and Clinical Practice. 83(3). 353–357. 21 indexed citations
7.
Gräs, Søren, et al.. (2000). Pituitary Adenylate Cyclase-Activating Peptide Stimulates Acute Progesterone Production in Rat Granulosa/Lutein Cells via Two Receptor Subtypes1. Biology of Reproduction. 63(1). 206–212. 29 indexed citations
8.
Hedetoft, Christoffer, et al.. (2000). Effect of Glucagon-Like Peptide 1(7-36)Amide in Insulin-Treated Patients with Diabetes Mellitus Secondary to Chronic Pancreatitis. Pancreas. 20(1). 25–31. 13 indexed citations
9.
Hedetoft, Christoffer, et al.. (1999). [Fatal poisoning with Letigen].. PubMed. 161(50). 6937–8. 2 indexed citations
10.
Hedetoft, Christoffer & H R Christensen. (1999). [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].. PubMed. 161(50). 6907–11. 7 indexed citations
11.
Fehmann, Hans-Christoph, et al.. (1997). Leptin: A Potent Inhibitor of Insulin Secretion. Peptides. 18(8). 1267–1273. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026